DE60220551D1 - Tabletten mit verzögerter wirkstofffreisetzung enthaltend indapamid - Google Patents

Tabletten mit verzögerter wirkstofffreisetzung enthaltend indapamid

Info

Publication number
DE60220551D1
DE60220551D1 DE60220551T DE60220551T DE60220551D1 DE 60220551 D1 DE60220551 D1 DE 60220551D1 DE 60220551 T DE60220551 T DE 60220551T DE 60220551 T DE60220551 T DE 60220551T DE 60220551 D1 DE60220551 D1 DE 60220551D1
Authority
DE
Germany
Prior art keywords
tablet
amount
total mass
indapamide
indapamid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60220551T
Other languages
English (en)
Other versions
DE60220551T2 (de
Inventor
Katarzyna Jureczek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pliva Krakow SA
Original Assignee
Pliva Krakow SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Krakow SA filed Critical Pliva Krakow SA
Application granted granted Critical
Publication of DE60220551D1 publication Critical patent/DE60220551D1/de
Publication of DE60220551T2 publication Critical patent/DE60220551T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60220551T 2002-07-01 2002-07-24 Tabletten mit verzögerter wirkstofffreisetzung enthaltend indapamid Expired - Lifetime DE60220551T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PL35482302 2002-07-01
PL354823A PL193976B1 (pl) 2002-07-01 2002-07-01 Tabletka o przedłużonym działaniu zawierająca indapamid i sposób wytwarzania tabletki o przedłużonym działaniu zawierającej indapamid
PCT/PL2002/000056 WO2004002475A1 (en) 2002-07-01 2002-07-24 Sustained release tablet containing indapamide

Publications (2)

Publication Number Publication Date
DE60220551D1 true DE60220551D1 (de) 2007-07-19
DE60220551T2 DE60220551T2 (de) 2008-02-07

Family

ID=29997631

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60220551T Expired - Lifetime DE60220551T2 (de) 2002-07-01 2002-07-24 Tabletten mit verzögerter wirkstofffreisetzung enthaltend indapamid

Country Status (6)

Country Link
US (1) US7553499B2 (de)
EP (1) EP1517683B1 (de)
AT (1) ATE363903T1 (de)
DE (1) DE60220551T2 (de)
PL (1) PL193976B1 (de)
WO (1) WO2004002475A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004005009A1 (de) * 2004-01-30 2005-09-01 Krka Tovarna Zdravil, D.D. Verzögert freisetzende pharmazeutische Zusammensetzung von Indapamid
FR2878748B1 (fr) 2004-12-07 2007-03-09 Arrow Generiques Soc Par Actio Formule de comprimes permettant une liberation prolongee d'indapamide apres administration par voie orale et procede de preparation
DE102004062257A1 (de) * 2004-12-23 2006-07-06 Merckle Gmbh Direkt verpresste Indapamid-Tabletten mit verzögerter Wirkstofffreisetzung
CN101773500B (zh) * 2010-02-09 2012-05-23 施慧达药业集团(吉林)有限公司 抗高血压的药物组合物
US8597683B2 (en) * 2010-11-30 2013-12-03 Watson Pharmaceuticals, Inc. Modified release tranexamic acid formulation
CN103142529B (zh) * 2013-03-07 2013-12-25 宁夏康亚药业有限公司 一种吲达帕胺缓释药物组合物及其制备方法
CN105012275B (zh) * 2015-08-20 2018-03-27 广东安诺药业股份有限公司 吲达帕胺缓释剂制备方法
CN111150713B (zh) * 2018-11-07 2023-02-10 珠海润都制药股份有限公司 一种吲达帕胺胶囊及其制备方法
CN112370433A (zh) * 2020-12-07 2021-02-19 石家庄市华新药业有限责任公司 一种吲达帕胺缓释片及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2529785A1 (fr) 1982-07-09 1984-01-13 Adir Composition pharmaceutique a base d'indapamide et de 8-(3-tertbutylamino 2-hydroxypropoxy)-thiachromanne
GB8502887D0 (en) 1985-02-05 1985-03-06 Sandoz Ltd Pharmaceutical compositions
HU196125B (en) 1985-02-05 1988-10-28 Sandoz Ag Process for producing pharmaceutical comprising 3-(aminopropoxy)-indole derivatives combined with diuretic
FR2677886B1 (fr) 1991-06-18 1995-03-31 Adir Comprime matriciel permettant la liberation prolongee d'indapamide apres administration par voie orale.
WO1996018386A1 (en) 1994-12-14 1996-06-20 Enbalt Trading Limited Pharmaceutical tablet formulations for direct compression
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
US6077534A (en) * 1997-09-02 2000-06-20 Klinge Pharma Gmbh Production of pharmaceutical formulations for treatment of edema and venous disorders

Also Published As

Publication number Publication date
DE60220551T2 (de) 2008-02-07
PL193976B1 (pl) 2007-04-30
WO2004002475A1 (en) 2004-01-08
US20050202086A1 (en) 2005-09-15
ATE363903T1 (de) 2007-06-15
US7553499B2 (en) 2009-06-30
EP1517683B1 (de) 2007-06-06
PL354823A1 (en) 2004-01-12
EP1517683A1 (de) 2005-03-30

Similar Documents

Publication Publication Date Title
NZ336789A (en) Use of methacrylic acid copolymer type C in the manufacture of tablets
HUP0101246A2 (hu) Meloxicam új galenusi formulációi orális alkalmazásra és eljárás az előállításukra
EA200801926A1 (ru) Таблетки парацетамола с быстрым высвобождением
SG146608A1 (en) Rapid dissolution formulation of a calcium receptor-active compound
UY25611A1 (es) Formas solidas de dosificacion oral para el tratamiento de diabetes no dependiente de insulina
UA88943C2 (ru) Быстрый способ влажного гранулирования для получения композиций, которые содержат кальций
IL187591A0 (en) Pharmaceutical composition as solid dosage from and method for manufacturing thereof
HRP20060136A2 (en) Pellets containing venflaxine hydrochloride
GR1003530B (el) Ταχεως διαλυομενες συνθεσεις εχουσες αναλγητικη δραση
EA200301040A1 (ru) Способ производства фармацевтической композиции низкой дозы
DE60220551D1 (de) Tabletten mit verzögerter wirkstofffreisetzung enthaltend indapamid
GEP20033062B (en) Pharmaceutical Composition Comprising Entacapone or Nitecapone and Cross-Linked Cellulose Derivative
RU2007119641A (ru) Композиция, включающая ацетаминофен, кофеин и необязательно аспирин в смеси со щелочным агентом для увеличения абсорбции
ATE329581T1 (de) Pharmazeutische formulierung, die n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydr -2h-(1, 3)oxazino(3,2-a)indol-10-carboxamid oder ein entsprechendes salz hiervon enthält, sowie deren herstellungsprozess, welcher trockengranulierung beinhaltet
AR018607A1 (es) Preparacion farmaceutica que en calidad de ingrediente activo contiene levotiroxina sodica, y un procedimiento para su preparacion
ZA200506992B (en) Fibrate tablet and method for the production thereof
MXPA05008403A (es) Uso de acido comestible en formas de dosis solidas farmaceuticas de rapida dispersion.
WO2007026261A3 (en) Formulations containing losartan and/or its salts
IL200447A0 (en) Compressed solid dosage form manufacturing process well-suited for use with drugs of low aqueous solubility and compressed solid dosage forms made thereby
WO2004105691A3 (en) Pharmaceutical compositions for oral administration comprising lithium carbonate
RU2007133793A (ru) Составы с контролируемым высвобождением альфузозина
ATE526961T1 (de) Pharmazeutische zusammensetzung mit atorvastatin als wirkstoff
RU2008141209A (ru) Лекарственная форма триметазидина модифицированного высвобождения и способ ее получения (варианты)
ATE331509T1 (de) Zusammensetzung die paracetamol und niflumic säure enthält
AR046493A2 (es) Composiciones farmaceuticas para el tratamiento o profilaxis de fibrilacion auricular y/o remodelado auricular

Legal Events

Date Code Title Description
8364 No opposition during term of opposition